Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression
Autor: | Misuzu Shimakage, Toshiyuki Sasagawa, Akira Yoshida, Masuo Yutsudo, Hirokazu Inoue, Kunimitsu Kawahara, Syunsuke Yanoma |
---|---|
Rok vydání: | 2003 |
Předmět: |
Epstein-Barr Virus Infections
Herpesvirus 4 Human Fluorescent Antibody Technique Biology Immunofluorescence medicine.disease_cause Pathology and Forensic Medicine Viral Matrix Proteins Thyroid carcinoma hemic and lymphatic diseases Carcinoma medicine Animals Humans RNA Messenger Thyroid Neoplasms In Situ Hybridization medicine.diagnostic_test Reverse Transcriptase Polymerase Chain Reaction Thyroid medicine.disease Epstein–Barr virus Carcinoma Papillary Blotting Southern Real-time polymerase chain reaction medicine.anatomical_structure Epstein-Barr Virus Nuclear Antigens Tumor progression DNA Viral Disease Progression Cancer research Epstein–Barr virus nuclear antigen 2 |
Zdroj: | Human Pathology. 34:1170-1177 |
ISSN: | 0046-8177 |
DOI: | 10.1053/j.humpath.2003.07.001 |
Popis: | There have been few studies regarding cancer progression from differentiated thyroid carcinoma to the undifferentiated one. To examine the possible involvement of Epstein-Barr virus (EBV) in this progression, 10 papillary carcinomas and 11 undifferentiated carcinomas were subjected to mRNA in situ hybridization, indirect immunofluorescence staining, polymerase chain reaction (PCR), and reverse-transcriptase PCR. mRNA in situ hybridization using a BamHIW probe revealed signals in all of the examined samples, although the signal strength was weaker in the papillary carcinomas than in the undifferentiated carcinomas. EBV nuclear antigen-2 (EBNA2) in situ hybridization produced almost the same results; however, the signals were detected less frequently in the papillary carcinomas. Indirect immunofluorescence using anti-EBNA2, anti-latent membrane protein-1 (LMP1), and anti-BZLF1 antibodies also showed positive results with high frequency and with more prominent fluorescence in undifferentiated carcinomas than in papillary carcinomas. An examination of thyroid carcinoma cell lines also confirmed these findings. EBV infected all of the thyroid carcinomas irrespective of the degree of pathological differentiation. The expression of EBV, especially of EBNA2 and LMP1 (both of which are oncogene products of EBV), was stronger in the undifferentiated carcinomas than in the papillary carcinomas. These results suggest that increased expression of EBV may be involved in the progression of thyroid papillary carcinoma to undifferentiated carcinoma. |
Databáze: | OpenAIRE |
Externí odkaz: |